These data – Page 3 – Communicable Diseases Research

Selective Electrochemical Detection of SARS-CoV-2 Using Deep Learning

Article

Published on 2022-08-302022-11-15
Journal: Viruses [Category] SARS, 치료기술,

UV 222 disinfection of SARS-CoV-2 in solution

용액 내 SARS-CoV-2의 UV 222 소독

Article

Published on 2022-08-252022-09-11
Journal: Scientific Reports [Category] SARS, 치료법,

Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination

중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)에 대한 광범위한 교차 반응성 항체의 숙주 예측 인자는 감염과 예방 접종 사이에 차이가 있습니다.

Observational Study

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 임상, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Against antibody Antibody Response B.1.1.7 B.1.351 B.1.617.2 BMI booster Clinical characteristics clinician Clinicians Cohort collected concern contributed coronavirus coronavirus 2 cross-reactive cross-reactive antibodies cross-reactive antibody disease severity enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay Factor Health healthy highest Host identify IgG IgG antibodies IgG antibody IgG level immunization Immunocompromised Immunoglobulin Immunoglobulin G individual Infection information metabolic health mounted mRNA vaccination P.1 participant plasma sample plasma samples Population populations predict prospective observational cohort Protective Protective antibody RBD Receptor binding domain Regression model regression models researchers respiratory responses SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severe acute respiratory syndrome Coronavirus Spike receptor binding domain tested These data vaccination Vaccine Variability variants variants of concern Viral Viral variants virus variants Wuhan younger people
[DOI] 10.1093/cid/ciab996 PMC 바로가기 [Article Type] Observational Study

Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes

BioNTech/Pfizer 코로나바이러스 질병 2019 중증 급성 호흡기 증후군 코로나바이러스 백신 접종에 대한 항체 반응 불량

Article

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus administration age antibody Antibody Response B.1.351 B.1.351 variant Belgium binding antibodies binding antibody BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccination Breakthrough infection cluster analysis comorbid conditions comparable coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 death detectable disease domain domains dose General population heterogeneity high risk home immunization Immunoglobulin immunosenescence IMPROVE in some Infection involved Messenger RNA mRNA mRNA vaccination mRNA vaccine Neutralizing Nursing nursing homes old age Poor RBD RBD IgG recruited related disease resident respiratory respond poorly Responder response S1 and S2 SARS-CoV-2 severe acute respiratory syndrome Coronavirus Support the vaccine These data vaccination Vaccine vaccine strain variants variants of concern were assessed wild type
[DOI] 10.1093/cid/ciab998 PMC 바로가기 [Article Type] Article

A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load

코로나19 고위험 보행 환자를 대상으로 한 밤라니비맙과 에테세비맙의 무작위 위약 대조 임상 시험 및 지속적으로 높은 바이러스 부하의 예후 가치 검증

Randomized Controlled Trial

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 임상, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age ambulatory ambulatory patient ambulatory patients antibody treatment applicability bamlanivimab baseline characterized clinical clinical status Cohort confidence interval coronavirus coronavirus disease Coronavirus disease 2019 correlated COVID-19 COVID-19 test Day death determine etesevimab expand first positive greater high risk Hospitalization infused Interim analyses interim analysis intravenously investigated load lower dose median median age Mild-to-moderate NCT04427501 occurred optimal dose outcome Patient persistently high viral load. phase Placebo placebo group receiving reduction in respiratory risk factor SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe COVID-19 Support the placebo group These data those receiving placebo Treatment Trial validation value variant Viral Viral load
[DOI] 10.1093/cid/ciab912 PMC 바로가기 [Article Type] Randomized Controlled Trial

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection

SARS-CoV-2 감염에 대한 항바이러스제의 효능을 평가하기 위한 SCID 마우스 모델

Article

Published on 2022-08-242022-09-11
Journal: Journal of Virology [Category] SARS, 변종, 치료제,

[키워드] ACE2 receptor acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Antiviral antiviral drug antiviral drugs antiviral efficacy antivirals B.1.351 B.1.351 variant BALB/c Beta Beta variant binding C57BL/6 CAGE coronavirus Culture drug hamsters Infection infectious virus titer infectious virus titers Infective dose inhibitors intrinsic lack log lung Lung pathology Lungs male mice Model moderate molnupiravir mouse mouse model Mouse models Nirmatrelvir offer Postinfection reagent receptor reduced replicate Replication reported SARS-CoV-2 SARS-CoV-2 mouse model SARS-CoV-2 strain SARS-CoV2 SCID significantly TCID These data tissue tissue culture twice a day Validity variant variants variants of concern Viral load virus virus strain wild-type
[DOI] 10.1128/jvi.00758-22 PMC 바로가기 [Article Type] Article

Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021

어린이의 다기관 염증 증후군 - 미국, 2020년 2월-2021년 7월

Article

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age B.1.617.2 baseline cardiovascular complication cardiovascular complications case report form CDC center Child children Clinical outcome clinical outcomes Cochran-Armitage test continuous variables Control coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination Critical care death declined Delta demographics disease control duration of hospitalization dysfunction ECMO Epidemiology extracorporeal membrane oxygenation gastrointestinal involvement hematologic Hospitalization Hyperinflammatory inclusion criteria increase in Infection Inflammatory information interquartile range Laboratory results male predominance mechanical ventilation median MIS-C Mortality multisystem inflammatory syndrome in children myocarditis National other variant other variants over pandemic Patient patient age prevention receipt renal renal failure reported SARS-CoV-2 study period Surveillance syndrome The United States These data trend United States variables were assessed
[DOI] 10.1093/cid/ciab1007 PMC 바로가기 [Article Type] Article

Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution

급성 질환 해결 후 1~8개월 후 코로나19 환자의 장내 세균총 이상 감지

Article

Published on 2022-08-172022-09-11
Journal: International Journal of Environmental Research an [Category] 치료제,

[키워드] acute COVID-19 acute disease acute phase adaptive immune responses addition alopecia anti-SARS-CoV-2 antibody Antibiotic therapy Antibiotics Anxiety bidirectional Bifidobacterium C-reactive protein Clinical data clinical manifestations controls COVID-19 severity Cytokine storm Depression Desulfovibrio detection disease DNA Dysbiosis Dyspnea evaluate fatigue Hypothesis immune response immune responses Immune status Interaction intestinal intestinal microbiota memory memory loss microbes microbiota modulating modulation Month myalgia pandemic Patient post-COVID-19 Post-COVID-19 patients Prevotella quantified reported symptoms Resolution Sequelae sequenced severity significant difference significant differences Stool stool samples target the patient Therapeutic approach These data use of antibiotics viral infections with COVID-19
[DOI] 10.3390/ijerph191610189 PMC 바로가기 [Article Type] Article

Evaluation of the effectiveness of surveillance policies to control the COVID-19 pandemic in São Paulo, Brazil

Article

Published on 2022-08-172022-11-16
Journal: Global Health Research and Policy [Category] 치료기술,

[키워드] Analysis Asymptomatic Brazil change changes in characterized Concentration conducted COVID-19 COVID-19 pandemic criteria database demographics disease Effectiveness effort evaluate genomic genomic sequence GISAID greater Health highlight Hospitalized increase in information Isolation Laboratory limit Local Molecular tests outcome outcomes pandemic Population Prevalence public health reductions in Regression model Result RHD RT-PCR RT-PCR public health testing policies RT-PCR test RT-PCR testing significantly state statistically significant Surveillance symptomatic Testing the mean These data Treatment virus Volume
[DOI] 10.1186/s41256-022-00260-4 PMC 바로가기

Resolving SARS-CoV-2 CD4 + T cell specificity via reverse epitope discovery

역 에피토프 발견을 통한 SARS-CoV-2 CD4 + T 세포 특이성 해결

Meta-Analysis

Published on 2022-08-162022-09-11
Journal: Cell Reports Medicine [Category] COVID19(2023년), SARS, 치료기술,

[키워드] Activation acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Antigen approach CD4 CD4 T cells Cluster coronavirus COVID-19 dataset detect epitope epitope discovery FIVE functional cell HLA identify immunodominant individual infected individuals information Intensive labor leukocyte Meta-analysis pathogen peptide peptide pool public T cell response. recognizing responses SARS-CoV-2 sequence similarity severe acute respiratory syndrome Coronavirus similarity single-cell specificity T cell T cell receptor T cell receptors T cell response T cells TCR TCR repertoire TCRs These data transgenic utility
[DOI] 10.1016/j.xcrm.2022.100697 PMC 바로가기 [Article Type] Meta-Analysis